How the public sector is working with private firms to fight COVID-19

How the public sector is working with private firms to fight COVID-19
Shortly after the World Health Organization learned of “a pneumonia of unknown cause … in Wuhan, China,” leading U.S. research firms started working around the clock to learn more about the novel coronavirus. In just three months, dozens of promising treatments and vaccines have entered the pipeline. Some are already in human trials.

This record-breaking pace is thanks, in part, to the dedicated efforts of America’s biopharmaceutical industry. Every day, our nation’s scientists research treatments for various diseases. That’s why the government can count on them in times of crisis.  

On March 24-25, I tuned in for a virtual summit hosted by the Biotechnology Innovation Organization, where industry leaders and senior government officials discussed the many ways they’re already working together to fast-track a cure. Participants also brainstormed other ways they might be able to cooperate.  

 
Sign Up for Our Email Newsletter

RECENT NEWS

Peter Pitts speaks to CNN about baby formula shortage
  • CNN
  • 05/13/2022 12:00 AM

Peter Pitts speaks to CNN about baby formula shortage

Former FDA Associate Commissioner Peter Pitts speaks with CNN on the shortage of baby formula on May 13, 2022....  Read more

Peter Pitts on the reported upcoming FDA ban on Juul with News Nation

Peter Pitts on the reported upcoming FDA ban on Juul with News Nation

Peter Pitts discusses a potential FDA ban on Juul with News Nation...  Read more

Peter Pitts joins NewsNation to discuss Abbott and the baby formula shortage

Peter Pitts joins NewsNation to discuss Abbott and the baby formula shortage

Peter Pitts, a former FDA Associate Commissioner, speaks about the baby formula shortage on News Nation...  Read more

DRUGWONKS BLOG